减重手术与病变肾脏:5年安全性与术后肾脏结局评估
该回顾性研究纳入302例术前2至5期慢性肾脏病(CKD)且BMI≥35 kg/m²的行初次腹腔镜减重手术患者,评估5年安全性及体重与肾脏结局。RYGB组5年总体重减轻百分比高于SG组(25.1% vs. 18.6%,p=0.036),但晚期并发症发生率更高(8.8% vs. 2.3%,p=0.014)。作者认为减重手术对CKD患者是有效的持续减重策略,并发症率可接受,未来需进一步研究确定其安全性。
要点
- RYGB组5年总体重减轻百分比高于SG组(25.1% vs. 18.6%,p=0.036)。
- RYGB组晚期并发症发生率高于SG组(8.8% vs. 2.3%,p=0.014)。
- 术前CKD 3期患者中43.2%改善至2期,5.1%进一步改善至1期。
核心结论
- 减重手术是CKD患者实现持续体重减轻的有效策略,并发症率可接受。
- RYGB带来更高的总体重减轻百分比,但晚期手术并发症可能性更高。
- 未来需进一步研究以确定减重手术在该人群中的安全性。
研究设计与样本
- 回顾性综述,纳入行初次腹腔镜减重手术且BMI≥35 kg/m²、术前诊断为CKD 2至5期的患者。
- 共纳入302例患者,其中SG 177例、RYGB 125例。
- CKD诊断与分期基于估算肾小球滤过率测量,依据既定指南。
- 在术后3、6、12、24和60个月测量人体测量学与肾脏结局。
主要发现
- 5年随访时,RYGB组总体重减轻百分比高于SG组(25.1% vs. 18.6%,p=0.036)。
- 尽管SG组患者CKD更晚期,RYGB组晚期并发症发生率显著更高,为11例(8.8%),SG组仅4例(2.3%)(p=0.014)。
- 术前CKD 3期患者中,76例(43.2%)改善至2期,另9例(5.1%)进一步改善至1期。
- 全部患者中63例(20.8%)最终成功接受肾移植。
- CKD 3期患者更倾向选择RYGB,而SG在4期和5期更常见。
局限性
- 未来需进一步研究以确定减重手术在该人群中的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity and its related medical conditions are well-established contributors to the development of chronic kidney disease (CKD). Metabolic and bariatric surgery (MBS), including procedures such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), is a potential intervention for these individuals. However, the heightened risk of postoperative complications casts doubts on the suitability of MBS in this population. Our aim is to evaluate the long-term safety, anthropometric and renal outcomes of MBS in patients with CKD. METHODS: A retrospective review of patients who underwent primary laparoscopic MBS with a BMI ≥ 35 kg/m2 and a preoperative diagnosis of stage 2 to 5 CKD. Criteria for CKD diagnosis and staging were based on estimated glomerular filtration rate measurements in accordance with established guidelines. Anthropometric and renal outcomes were measured at 3-, 6-, 12-, 24- and 60-months postoperatively. RESULTS: A total of 302 patients (177 SG, 125 RYGB) were included. RYGB was preferred for patients with stage 3 CKD, while SG was more common in stages 4 and 5. At 5-year follow-up, percentage of total weight loss was higher in the RYGB cohort compared to SG (25.1% vs. 18.6%, p = 0.036). Despite SG patients having more advanced CKD, the incidence of late complications was significantly higher following RYGB, with 11 incidents (8.8%), compared to the SG cohort with only 4 cases (2.3%) (p = 0.014). In those with preoperative CKD stage 3, 76 patients (43.2%) improved to stage 2, with another 9 patients (5.1%) improving further to stage 1. Of all patients, 63 (20.8%) eventually received a successful renal transplant. CONCLUSIONS: MBS is an effective strategy for sustained weight loss in patients with CKD with acceptable complications rates. RYGB leads to a higher percentage of overall weight loss, albeit with an elevated likelihood of late surgical complications. Future studies are needed to determine the safety of MBS in this demographic.
引用
- Abi Mosleh K, Sample JW, Belluzzi A, et al. Bariatric surgery and the diseased kidney: a 5-year assessment of safety and postoperative renal outcomes. Surg Endosc. 2024. PMID: 38872021. doi:10.1007/s00464-024-10983-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。